196 related articles for article (PubMed ID: 27866277)
1. Identification of Key Cost Generating Events for Idiopathic Pulmonary Fibrosis: A Systematic Review.
Vaidya S; Hibbert CL; Kinter E; Boes S
Lung; 2017 Feb; 195(1):1-8. PubMed ID: 27866277
[TBL] [Abstract][Full Text] [Related]
2. Health care utilization and costs of idiopathic pulmonary fibrosis in U.S. Medicare beneficiaries aged 65 years and older.
Collard HR; Chen SY; Yeh WS; Li Q; Lee YC; Wang A; Raghu G
Ann Am Thorac Soc; 2015 Jul; 12(7):981-7. PubMed ID: 25923447
[TBL] [Abstract][Full Text] [Related]
3. Hospital cost and length of stay in idiopathic pulmonary fibrosis.
Mooney JJ; Raimundo K; Chang E; Broder MS
J Med Econ; 2017 May; 20(5):518-524. PubMed ID: 28092235
[TBL] [Abstract][Full Text] [Related]
4. Patterns and Economic Burden of Hospitalizations and Exacerbations Among Patients Diagnosed with Idiopathic Pulmonary Fibrosis.
Yu YF; Wu N; Chuang CC; Wang R; Pan X; Benjamin NN; Devercelli G; Coultas DB
J Manag Care Spec Pharm; 2016 Apr; 22(4):414-23. PubMed ID: 27023695
[TBL] [Abstract][Full Text] [Related]
5. The burden of idiopathic pulmonary fibrosis: an unmet public health need.
Lee AS; Mira-Avendano I; Ryu JH; Daniels CE
Respir Med; 2014 Jul; 108(7):955-67. PubMed ID: 24780718
[TBL] [Abstract][Full Text] [Related]
6. The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study.
Cox IA; de Graaff B; Ahmed H; Campbell J; Otahal P; Corte TJ; Moodley Y; Goh N; Hopkins P; Macansh S; Walters EH; Palmer AJ
Eur J Health Econ; 2023 Sep; 24(7):1121-1139. PubMed ID: 36289130
[TBL] [Abstract][Full Text] [Related]
7. Treatment patterns, resource use and costs of idiopathic pulmonary fibrosis in Spain--results of a Delphi Panel.
Morell F; Esser D; Lim J; Stowasser S; Villacampa A; Nieves D; Brosa M
BMC Pulm Med; 2016 Jan; 16():7. PubMed ID: 26758510
[TBL] [Abstract][Full Text] [Related]
8. The Burden of Illness of Idiopathic Pulmonary Fibrosis: A Comprehensive Evidence Review.
Diamantopoulos A; Wright E; Vlahopoulou K; Cornic L; Schoof N; Maher TM
Pharmacoeconomics; 2018 Jul; 36(7):779-807. PubMed ID: 29492843
[TBL] [Abstract][Full Text] [Related]
9. Health care burden and medical resource utilisation of idiopathic pulmonary fibrosis in Korea.
Kim SW; Myong JP; Yoon HK; Koo JW; Kwon SS; Kim YH
Int J Tuberc Lung Dis; 2017 Feb; 21(2):230-235. PubMed ID: 28234090
[TBL] [Abstract][Full Text] [Related]
10. Clinical and economic burden of idiopathic pulmonary fibrosis: a retrospective cohort study.
Raimundo K; Chang E; Broder MS; Alexander K; Zazzali J; Swigris JJ
BMC Pulm Med; 2016 Jan; 16():2. PubMed ID: 26732054
[TBL] [Abstract][Full Text] [Related]
11. Characterizing Health Outcomes in Idiopathic Pulmonary Fibrosis using US Health Claims Data.
Mortimer KM; Bartels DB; Hartmann N; Capapey J; Yang J; Gately R; Enger C
Respiration; 2020; 99(2):108-118. PubMed ID: 31982886
[TBL] [Abstract][Full Text] [Related]
12. Strategies to manage costs in idiopathic pulmonary fibrosis.
Owens GM
Am J Manag Care; 2017 Jul; 23(11 Suppl):S191-S196. PubMed ID: 28978214
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology, healthcare utilization, and related costs among patients with IPF: results from a German claims database analysis.
Kreuter M; Picker N; Schwarzkopf L; Baumann S; Cerani A; Postema R; Maywald U; Dittmar A; Langley J; Patel H
Respir Res; 2022 Mar; 23(1):62. PubMed ID: 35305632
[TBL] [Abstract][Full Text] [Related]
14. Hospital-Based Resource Use and Costs Among Patients With Idiopathic Pulmonary Fibrosis Enrolled in the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry.
Fan Y; Bender SD; Conoscenti CS; Davidson-Ray L; Cowper PA; Palmer SM; de Andrade JA;
Chest; 2020 Jun; 157(6):1522-1530. PubMed ID: 32004554
[TBL] [Abstract][Full Text] [Related]
15. Health Care Costs at the End of Life for Patients with Idiopathic Pulmonary Fibrosis. Evaluation of a Pilot Multidisciplinary Collaborative Interstitial Lung Disease Clinic.
Kalluri M; Lu-Song J; Younus S; Nabipoor M; Richman-Eisenstat J; Ohinmaa A; Bakal JA
Ann Am Thorac Soc; 2020 Jun; 17(6):706-713. PubMed ID: 32197048
[No Abstract] [Full Text] [Related]
16. Mechanical ventilation in idiopathic pulmonary fibrosis: a nationwide analysis of ventilator use, outcomes, and resource burden.
Mooney JJ; Raimundo K; Chang E; Broder MS
BMC Pulm Med; 2017 May; 17(1):84. PubMed ID: 28532459
[TBL] [Abstract][Full Text] [Related]
17. Impact of Idiopathic Pulmonary Fibrosis on Longitudinal Health-care Utilization in a Community-Based Cohort of Patients.
Farrand E; Iribarren C; Vittinghoff E; Levine-Hall T; Ley B; Minowada G; Collard HR
Chest; 2021 Jan; 159(1):219-227. PubMed ID: 32717266
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic Pulmonary Fibrosis: Utilization of Health Services and Out-Of-Pocket Health Expenditures in Greece.
Naoum P; Athanasakis K; Skroumpelos A; Kyriopoulos J
Value Health Reg Issues; 2020 Sep; 22():44-48. PubMed ID: 32777730
[TBL] [Abstract][Full Text] [Related]
19. Improving outcomes and managing costs in idiopathic pulmonary fibrosis.
Morrow T
Am J Manag Care; 2019 Jul; 25(11 Suppl):S204-S209. PubMed ID: 31419090
[TBL] [Abstract][Full Text] [Related]
20. Burden of illness in idiopathic pulmonary fibrosis.
Collard HR; Ward AJ; Lanes S; Cortney Hayflinger D; Rosenberg DM; Hunsche E
J Med Econ; 2012; 15(5):829-35. PubMed ID: 22455577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
